Should You Avoid Neurocrine Biosciences, Inc. (NBIX)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (......(read more)
Posts Tagged ‘Is NBIX A Good Stock To Buy?’
Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published this article and predicted that a......(read more)
How Did Neurocrine Biosciences, Inc. (NBIX) Compare Against Top Hedge Fund Stocks in 2019?
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers......(read more)
Hedge Funds Have Never Been This Bullish On Neurocrine Biosciences, Inc. (NBIX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook......(read more)
Were Hedge Funds Right About Piling Into Neurocrine Biosciences (NBIX)?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors......(read more)
Hedge Funds Are Dumping Neurocrine Biosciences, Inc. (NBIX)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......(read more)
Did Hedge Funds Drop The Ball On Neurocrine Biosciences, Inc. (NBIX) ?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due......(read more)
Should You Buy Neurocrine Biosciences, Inc. (NBIX)?
During the first half of the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by about 4 percentage points as investors......(read more)
Is Neurocrine Biosciences, Inc. (NBIX) a Good Stock to Buy?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment......(read more)
Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
Joseph Edelman‘s Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being......(read more)
Hedge Funds Growing Fond Of Neurocrine Biosciences, Inc. (NBIX)
Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive......(read more)
